NDC11 76282064137
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 76282-0641-37 | 76282-0641 |
| 76282-641-37 | 76282-641 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Budesonide Inhalation Suspension | BUDESONIDE | Exelan Pharmaceuticals, Inc. | d9656442-4587-4867-9a8c-5f5b0402936e | 2020-12-11 | Warnings, Adverse reactions | 76282-641-37 76282-641 76282064137 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.